Reduced Seminal Concentration of CD45pos Cells after Follicle-Stimulating Hormone Treatment in Selected Patients with Idiopathic Oligoasthenoteratozoospermia

Table 2

Correlation analysis between semen concentrations of CD45pos cells and other sperm and hormonal parameters before and after treatment (𝑛=54 patients).

Parameter	CD45pos cells (before treatment)	CD45pos cells (after treatment)
Semen volume (mL)	𝑟=0.45;𝑃=NS	𝑟=0.40;𝑃=NS
Semen pH	𝑟=0.54;𝑃=NS	𝑟=0.50;𝑃=NS
Total sperm count (million)	𝑟=−0.58;𝑃=NS	𝑟=−0.54;𝑃=NS
Sperm density (million/mL)	𝑟=−0.47;𝑃=NS	𝑟=−0.42;𝑃=NS
Spermatozoa with normal morphology (%)	𝑟=−0.75;𝑃<0.05	𝑟=−0.73;𝑃<0.05
Spermatozoa with progressive motility (%)	𝑟=−0.63;𝑃=NS	𝑟=−0.60;𝑃=NS
Immature germ elements (%)	𝑟=0.88;𝑃<0.05	𝑟=0.85;𝑃<0.05
Peroxidase-positive leukocytes (million/mL)	𝑟=0.45;𝑃=NS	𝑟=0.43;𝑃=NS
Serum FSH (mIU mL^−1)	𝑟=0.52;𝑃=NS	𝑟=0.51;𝑃=NS
Serum LH (mIU mL^−1)	𝑟=0.47;𝑃=NS	𝑟=0.44;𝑃=NS
Serum total testosterone (ng mL^−1)	𝑟=−0.63;𝑃=NS	𝑟=−0.60;𝑃=NS
Serum estradiol (pg mL^−1)	𝑟=0.59;𝑃=NS	𝑟=0.55;𝑃=NS
Serum prolactin (ng mL^−1)	𝑟=0.40;𝑃=NS	𝑟=0.30;𝑃=NS